| 期 |
栏目 |
标题 |
文件 |
| 卷 30, 编号 7 (2019) |
Articles |
COMPLICATIONS OF DIABETES MELLITUS IN ITS CONCURRENCE WITH PULMONARY TUBERCULOSIS |
|
| 卷 31, 编号 2 (2020) |
Articles |
Pulmonary tuberculosis and malignant neoplasms |
|
| 卷 31, 编号 5 (2020) |
Articles |
Laboratory indicators of coronavirus infection COVID-19 |
|
| 卷 31, 编号 7 (2020) |
Articles |
ADVERSE REACTIONS TO ANTI-TUBERCULOSIS DRUGS IN PATIENTS WITH PULMONARY TUBERCULOSIS WITH CONCOMITANT DIABETES MELLITUS |
|
| 卷 31, 编号 11 (2020) |
Articles |
Hyperuricemia and tuberculosis |
|
| 卷 32, 编号 4 (2021) |
Articles |
THE GUT MICROBIOTA IN PATIENTS WITH NEW-ONSET PULMONARY TUBERCULOSIS |
|
| 卷 32, 编号 5 (2021) |
Articles |
Markers of the hemostatic and fibrinolytic systems in patients with surgical tuberculosis who have experienced COVID-19 |
|
| 卷 33, 编号 7 (2022) |
From Practice |
Indicators of clinical and biochemical blood tests in patients with the extremely severe course of the novel coronavirus infection COVID-19 |
|
| 卷 33, 编号 10 (2022) |
Articles |
A CHANGE IN GUT MICROBIOTA PARAMETERS ACCORDING TO THE CHARACTERISTICS OF THE COURSE OF THE TUBERCULOSIS PROCESS |
|
| 卷 23, 编号 2 (2012) |
Articles |
SSHIFTS IN THE HEMOSTATIC SYSTEM ARE A COMPONENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME IN PULMONARY TUBERCULOSIS |
|
| 卷 28, 编号 2 (2017) |
Articles |
THE PREVALENCE AND CLINICAL MANIFESTATIONS OF TUBERCULOSIS AND THE EFFICIENCY OF ITS TREATMENT IN PATIENTS WITH DIABETES MELLITUS |
|
| 卷 28, 编号 8 (2017) |
Articles |
THYROID FUNCTION IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS |
|
| 卷 28, 编号 11 (2017) |
Articles |
A SYSTEMIC INFLAMMATORY RESPONSE IN PATIENTS WITH TUBERCULOSIS AND HIV INFECTION |
|
| 卷 29, 编号 11 (2018) |
Articles |
Tuberculosis in HIV-infected patients: prevalence, clinical manifestations, treatment efficiency |
|
| 卷 29, 编号 12 (2018) |
Articles |
Features of tuberculosis in its concurrence with diabetes mellitus and HIV infection |
|
| 卷 34, 编号 7 (2023) |
From Practice |
A clinical case of an individual approach in the treatment of a patient with tuberculosis of the lungs and bronchus in combination with mycobacteriosis and Crohn's disease |
|
| 卷 34, 编号 8 (2023) |
Problem |
Tuberculosis and diabetes mellitus: the current state of the problem |
|
| 卷 34, 编号 12 (2023) |
From Practice |
Indicators of hemostasis and fibrinolysis systems and systemic inflammatory response in patients with newly diagnosed sarcoidosis after COVID-19 |
|
| 卷 35, 编号 2 (2024) |
Topical Subject |
Indicators of hemostasis and fibrinolysis systems, clinical blood count and C-reactive protein in patients with chronic obstructive pulmonary disease after SARS-CoV-2 infection |
|
| 卷 35, 编号 2 (2024) |
From Practice |
An integrated approach in the treatment of a patient with pulmonary tuberculosis and tracheobronchial tree with psychological support |
|
